192 related articles for article (PubMed ID: 37031183)
21. IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma.
Cheng BY; Lau EY; Leung HW; Leung CO; Ho NP; Gurung S; Cheng LK; Lin CH; Lo RC; Ma S; Ng IO; Lee TK
Cancer Res; 2018 May; 78(9):2332-2342. PubMed ID: 29483095
[TBL] [Abstract][Full Text] [Related]
22. PINK1 positively regulates IL-1β-mediated signaling through Tollip and IRAK1 modulation.
Lee HJ; Chung KC
J Neuroinflammation; 2012 Dec; 9():271. PubMed ID: 23244239
[TBL] [Abstract][Full Text] [Related]
23. IRAK1 and IRAK4 promote phosphorylation, ubiquitination, and degradation of MyD88 adaptor-like (Mal).
Dunne A; Carpenter S; Brikos C; Gray P; Strelow A; Wesche H; Morrice N; O'Neill LA
J Biol Chem; 2010 Jun; 285(24):18276-82. PubMed ID: 20400509
[TBL] [Abstract][Full Text] [Related]
24. miR-142a-3p Enhances FlaA N/C Protection Against Radiation-Mediated Intestinal Injury by Modulating the IRAK1/NF-κB Signaling Pathway.
Liu T; Wu DM; Zhang F; Zhang T; He M; Zhao YY; Li J; Li L; Xu Y
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1256-1268. PubMed ID: 34906656
[TBL] [Abstract][Full Text] [Related]
25. Identification of optineurin as an interleukin-1 receptor-associated kinase 1-binding protein and its role in regulation of MyD88-dependent signaling.
Tanishima M; Takashima S; Honda A; Yasuda D; Tanikawa T; Ishii S; MaruYama T
J Biol Chem; 2017 Oct; 292(42):17250-17257. PubMed ID: 28882891
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7.
Pan SJ; Zhan SK; Ji WZ; Pan YX; Liu W; Li DY; Huang P; Zhang XX; Cao CY; Zhang J; Bian LG; Sun B; Sun QF
Sci Rep; 2015 Jun; 5():11066. PubMed ID: 26067607
[TBL] [Abstract][Full Text] [Related]
27. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity.
Hsieh CH; Lee CH; Liang JA; Yu CY; Shyu WC
Oncol Rep; 2010 Dec; 24(6):1629-36. PubMed ID: 21042761
[TBL] [Abstract][Full Text] [Related]
28. Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p.
Sun Y; Wang J; Ma Y; Li J; Sun X; Zhao X; Shi X; Hu Y; Qu F; Zhang X
J Exp Clin Cancer Res; 2021 Sep; 40(1):306. PubMed ID: 34587992
[TBL] [Abstract][Full Text] [Related]
29. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.
Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL
Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672
[TBL] [Abstract][Full Text] [Related]
30. Redox proteomics reveal stress responsive proteins linking peroxiredoxin-1 status in glioma to chemosensitivity and oxidative stress.
Poschmann G; Grzendowski M; Stefanski A; Bruns E; Meyer HE; Stühler K
Biochim Biophys Acta; 2015 Jun; 1854(6):624-31. PubMed ID: 25484280
[TBL] [Abstract][Full Text] [Related]
31. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-153-3p enhances cell radiosensitivity by targeting BCL2 in human glioma.
Sun D; Mu Y; Piao H
Biol Res; 2018 Dec; 51(1):56. PubMed ID: 30537994
[TBL] [Abstract][Full Text] [Related]
33. RNF216 Alleviates Radiation-Induced Apoptosis and DNA Damage Through Regulating Ubiquitination-Mediated Degradation of p53 in Glioblastoma.
Xie S; Hong Z; Li Y; Wang J; Wang J; Li S; Liu Y
Mol Neurobiol; 2022 Aug; 59(8):4703-4717. PubMed ID: 35594003
[TBL] [Abstract][Full Text] [Related]
34. LINC00963-FOSB-mediated transcription activation of UBE3C enhances radioresistance of breast cancer cells by inducing ubiquitination-dependent protein degradation of TP73.
Wang Y; Liu M; Liu X; Guo X
J Transl Med; 2023 May; 21(1):321. PubMed ID: 37173692
[TBL] [Abstract][Full Text] [Related]
35. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis.
Cai H; Yu Y; Ni X; Li C; Hu Y; Wang J; Chen F; Xi S; Chen Z
Cell Death Dis; 2020 Dec; 11(12):1032. PubMed ID: 33268783
[TBL] [Abstract][Full Text] [Related]
36. Long intergenic non-protein coding RNA 960 regulates cancer cell viability, migration and invasion through modulating miR-146a-5p/interleukin 1 receptor associated kinase 1 axis in pancreatic ductal adenocarcinoma.
Huang Y; Yan Q; Yu D; Sun X; Jiang S; Li W; Jia L
Bioengineered; 2021 Dec; 12(1):369-381. PubMed ID: 33380238
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase.
Windheim M; Stafford M; Peggie M; Cohen P
Mol Cell Biol; 2008 Mar; 28(5):1783-91. PubMed ID: 18180283
[TBL] [Abstract][Full Text] [Related]
38. IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies.
Cai B; Liu Y; Chong Y; Zhang H; Matsunaga A; Fang X; Pacholczyk R; Zhou G; Cowell JK; Hu T
Mol Cancer; 2021 Dec; 20(1):165. PubMed ID: 34906138
[TBL] [Abstract][Full Text] [Related]
39. [MiR-142-3p inhibits lipopolysaccharide-induced inflammatory response in human periodontal ligament cells through targeting IRAK1].
Hu HY; Wang JQ
Shanghai Kou Qiang Yi Xue; 2016 Dec; 25(6):682-687. PubMed ID: 28275790
[TBL] [Abstract][Full Text] [Related]
40. IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma.
Chou CK; Chi SY; Huang CH; Chou FF; Huang CC; Liu RT; Kang HY
J Clin Endocrinol Metab; 2016 Nov; 101(11):4357-4366. PubMed ID: 27533309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]